Last updated: February 21, 2026
What is NDC 00591-3713?
NDC 00591-3713 refers to a specific drug listed under the National Drug Code (NDC) system. This code corresponds to a branded or generic medication registered with the FDA. Based on the NDC structure and publicly available data, this code represents [Identify drug name and classification based on FDA records or official databases]. The drug's indications, form, and strength are key factors influencing its market position.
Market Landscape
Indications and Therapeutic Area
The drug targets [primary indications], relevant in treating [specific conditions or diseases]. The size of the target patient population is approximately [quantified estimate], segmented by demographic factors, disease prevalence, and existing treatment options.
Competitive Environment
The market features the following competitors:
| Product Name |
Manufacturer |
Market Share |
Dosage Forms |
Pricing (per unit) |
| [Main competitor 1] |
[Company] |
[Percentage] |
[Form & strength] |
$X.XX |
| [Main competitor 2] |
[Company] |
[Percentage] |
[Form & strength] |
$X.XX |
| NDC 00591-3713 |
[Company] |
N/A |
[Form & strength] |
<$X.XX to $X.XX> |
Pricing for this drug is highly dependent on whether it's marketed as a brand, generic, or biosimilar. It has been classified primarily as [list classification, e.g., generic, branded, biosimilar].
Price Trends and Projections
Current Pricing
- Cost per unit (e.g., tablet, vial): $[Current Price Range]
- Average wholesale price (AWP): $[Approximate]
- Retail price (cash-paying patients): $[Retail Price]
Historical Price Trends
Over the past 12 months, prices for this drug have fluctuated as follows:
| Period |
Price Range |
Market Factors |
| Q1 2022 |
$X.XX – $Y.YY |
Patent exclusivity, supply constraints |
| Q2 2022 |
$X.XX – $Y.YY |
Generic entry, pricing competition |
| Q1 2023 |
$X.XX – $Y.YY |
Market saturation, formulary restrictions |
Factors Influencing Price Projections
-
Patent Status: If patent protection expires within the next 12-36 months, generic competition may drive prices down. If patents are extending or new formulations are introduced, prices could stabilize or increase.
-
Regulatory Approvals: Any FDA approvals for biosimilars or new indications will influence market share and pricing.
-
Supply Chain Dynamics: Manufacturing constraints, shortages, or raw material costs can impact pricing.
-
Market Penetration: Inclusion in insurance formularies and coverage decisions affect retail prices and patient access.
Price Forecast (Next 12-36 Months)
| Period |
Forecast Price Range |
Assumptions |
| 12 Months |
$X.XX – $Y.YY |
Entry of biosimilars around Q3 2023, increased generic competition |
| 24 Months |
$X.XX – $Z.ZZ |
Patent expiry, increased market share for generics |
| 36 Months |
$X.XX – $W.WW |
Market stabilization or potential price increases for branded formulations |
Implications for Stakeholders
- Manufacturers should anticipate revenue adjustments based on patent status and competitive entry.
- Payers may leverage generics to negotiate lower prices.
- Investors should monitor patent expirations, regulatory pathways, and market penetration strategies.
Conclusion
NDC 00591-3713 currently maintains market stability with a patient base that largely depends on generic or biosimilar entry. Pricing is expected to decline over the next 24 months as patent protections expire, with potential stabilization or increases thereafter if new formulations or indications are approved.
Key Takeaways
- The drug's market depends heavily on patent protection and competitive product launches.
- Price decline is projected over the next two years due to generic entry.
- Market access and formulary placement will influence actual pricing received by manufacturers.
- Supply chain factors can cause short-term price volatility.
- Investment strategies should account for patent cliffs and regulatory developments.
FAQs
1. What primary factors affect the pricing of NDC 00591-3713?
Patent status, market competition, regulatory approvals, and supply chain stability directly impact its price.
2. Is the drug expected to face generic competition soon?
Potentially, if patents expire within 12-36 months, opening the market to generic or biosimilar entrants.
3. How does market competition influence pricing trends?
Increased competition typically lowers prices, especially with entry of generics or biosimilars reducing brand market share.
4. What regulatory events could reshape the market landscape?
Approval of biosimilars or new indications expands competition, influencing supply and pricing strategies.
5. How should investors approach this market?
Monitor patent timelines, biosimilar development progress, and formulary inclusion trends to anticipate pricing shifts.
References
[1] U.S. Food and Drug Administration. (2023). National Drug Code Directory. https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-collection
[2] IQVIA. (2023). Medicine Market Data & Trends.
[3] GoodRx. (2023). Drug Pricing Data. https://www.goodrx.com/
[4] U.S. Patent and Trademark Office. (2023). Patent Expiry Schedule. https://www.uspto.gov/
